We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
Cap. Flow
-$2.79B
Cap. Flow %
-20.16%
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$66.4M
2
VLO icon
Valero Energy
VLO
+$28.9M
3
SLB icon
SLB Ltd
SLB
+$24.8M
4
BNY
Bank of New York Mellon
BNY
+$22.6M
5
PEP icon
PepsiCo
PEP
+$20.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$182M
2
AAPL icon
Apple
AAPL
+$148M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.9M
4
AMGN icon
Amgen
AMGN
+$72.1M
5
TSLA icon
Tesla
TSLA
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.26%
2 Technology 28.78%
3 Financials 8.15%
4 Consumer Discretionary 7.54%
5 Industrials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CF icon
626
CF Industries
CF
$18.4B
$667K ﹤0.01%
9,612
-16,284
-63% -$1.14M
AEM icon
627
Agnico Eagle Mines
AEM
$73B
$660K ﹤0.01%
13,201
+902
+7% +$48.8K
UTHR icon
628
United Therapeutics
UTHR
$26.3B
$659K ﹤0.01%
2,984
-4,597
-61% -$1.02M
DPZ icon
629
Domino's
DPZ
$11.4B
$652K ﹤0.01%
1,935
-341
-15% -$108K
POOL icon
630
Pool Corp
POOL
$6.73B
$620K ﹤0.01%
567
-2,200
-80% -$752K
KEY icon
631
KeyCorp
KEY
$24.1B
$607K ﹤0.01%
65,716
-54,428
-45% -$568K
VTRS icon
632
Viatris
VTRS
$20.5B
$599K ﹤0.01%
60,008
-4,317
-7% -$41.2K
DLB icon
633
Dolby
DLB
$4.85B
$568K ﹤0.01%
+6,785
New +$567K
TFX icon
634
Teleflex
TFX
$5.8B
$552K ﹤0.01%
2,280
-2,860
-56% -$716K
ETR icon
635
Entergy
ETR
$53.1B
$550K ﹤0.01%
11,292
SU icon
636
Suncor Energy
SU
$75.6B
$543K ﹤0.01%
18,487
BURL icon
637
Burlington
BURL
$22.5B
$537K ﹤0.01%
3,410
-3,672
-52% -$630K
CTLT
638
DELISTED
CATALENT, INC.
CTLT
$532K ﹤0.01%
12,280
-16,310
-57% -$716K
RPTX
639
DELISTED
Repare Therapeutics
RPTX
$529K ﹤0.01%
+50,001
New +$515K
EPAM icon
640
EPAM Systems
EPAM
$4.92B
$515K ﹤0.01%
2,290
-4,390
-66% -$1.11M
ETSY icon
641
Etsy
ETSY
$7.96B
$502K ﹤0.01%
5,929
-9,361
-61% -$883K
FCNCA icon
642
First Citizens BancShares
FCNCA
$24.3B
$498K ﹤0.01%
+388
New +$449K
XP icon
643
XP
XP
$8.65B
$469K ﹤0.01%
+20,000
New +$339K
WOLF icon
644
Wolfspeed
WOLF
$1.24B
$444K ﹤0.01%
7,994
-23,844
-75% -$1.21M
QSR icon
645
Restaurant Brands International
QSR
$25.8B
$437K ﹤0.01%
5,633
+1,975
+54% +$143K
FNV icon
646
Franco-Nevada
FNV
$41.4B
$433K ﹤0.01%
3,036
RCI icon
647
Rogers Communications
RCI
$17.7B
$416K ﹤0.01%
9,099
-27,226
-75% -$1.28M
COIN icon
648
Coinbase
COIN
$44.1B
$403K ﹤0.01%
5,639
JEF icon
649
Jefferies Financial Group
JEF
$13B
$391K ﹤0.01%
11,780
-395,933
-97% -$12.4M
WFC icon
650
Wells Fargo
WFC
$264B
$385K ﹤0.01%
9,028
+1,871
+26% +$75.3K

Similar funds

Candriam SCA's Q2 2023 Portfolio in Review

As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.

  • Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
  • Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
  • Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
  • Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
  • Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
  • Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.